In modern medicinal chemistry, process development, and active pharmaceutical ingredient (API) manufacturing, introducing sterically hindered branched carboxylic acid scaffolds into small-molecule drug candidates provides a method for modifying metabolic stability and receptor binding affinity. Medications targeting cardiovascular diseases, metabolic disorders, and specialized enzyme pathways...

The integration of fluorine atoms into organic molecules has revolutionized the pharmaceutical industry. The presence of fluorine dramatically alters a drug's physicochemical properties, enhancing its metabolic stability, increasing its lipophilicity for better cell membrane penetration, and improving its binding affinity to target proteins. However, synthesizing these complex fluorinated...